Compare GERN & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GERN | UTF |
|---|---|---|
| Founded | 1990 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.3M | 2.4B |
| IPO Year | 1996 | N/A |
| Metric | GERN | UTF |
|---|---|---|
| Price | $1.37 | $23.89 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 171.7K |
| Earning Date | 02-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.84 |
| Revenue | ★ $183,403,000.00 | $138,636,669.00 |
| Revenue This Year | $147.42 | N/A |
| Revenue Next Year | $39.42 | N/A |
| P/E Ratio | ★ N/A | $9.16 |
| Revenue Growth | ★ 522.13 | 19.80 |
| 52 Week Low | $1.04 | $22.05 |
| 52 Week High | $3.59 | $26.53 |
| Indicator | GERN | UTF |
|---|---|---|
| Relative Strength Index (RSI) | 57.05 | 46.96 |
| Support Level | $1.30 | $24.13 |
| Resistance Level | $1.37 | $24.48 |
| Average True Range (ATR) | 0.06 | 0.28 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 43.33 | 44.44 |
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.